DiaGenic and GE team up on test to pinpoint Alzheimer's risk
This article was originally published in Clinica
Executive Summary
Norwegian diagnostics company DiaGenic is collaborating with imaging giant GE Healthcare to develop a blood test for mild cognitive impairment (MCI), thought to be a precursor of Alzheimer's disease.